Hims & Hers Health, Inc. (HIMS) Misses Q2 EPS by 2c

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $113.6 million versus the consensus estimate of $103.89 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Oral Wegovy reaches 33% of total prescriptions by May
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance